Loading insider details...
Beta
Latest Form 4 (Jul 18, 2026): Grant/Award of 4,406 shares.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 18, 2026 | Keenova Therapeutics plc | Grant/Award | 4,406 | n/a |
| Jul 18, 2026 | Keenova Therapeutics plc | Exercise/Conversion | 2,685 | n/a |
| Feb 26, 2026 | Keenova Therapeutics plc | Grant/Award | 3,984 | n/a |
| Jul 5, 2024 | Cencora, Inc. (COR) | Grant/Award | 67 | $12.8K |
| Jul 2, 2024 | Cencora, Inc. (COR) | Exercise/Conversion | 1,432 | n/a |
| Jan 8, 2024 | Cencora, Inc. (COR) | Grant/Award | 40 | $7.0K |
| Dec 26, 2023 | Cencora, Inc. (COR) | Sale | 3,400 | $687.2K |
| Nov 15, 2023 | Cencora, Inc. (COR) | Exercise/Conversion | 3,387 | $291.6K |
| Nov 14, 2023 | Cencora, Inc. (COR) | Exercise/Conversion | 1,333 | n/a |
| Nov 13, 2023 | Cencora, Inc. (COR) | Grant/Award | 10,052 | n/a |